Pam Marrone, founder and CEO of Marrone Bio Innovations, looks over nematode testing with nematologist Julius Passion at the company’s headquarter in Davis in 2016. The biotech firm on Wednesday reported a net loss of $31 million for all of 2016. Revenue increased to $14 million, up from $9.8 million in 2015.
Pam Marrone, founder and CEO of Marrone Bio Innovations, looks over nematode testing with nematologist Julius Passion at the company’s headquarter in Davis in 2016. The biotech firm on Wednesday reported a net loss of $31 million for all of 2016. Revenue increased to $14 million, up from $9.8 million in 2015. Manny Crisostomo Sacramento Bee file
Pam Marrone, founder and CEO of Marrone Bio Innovations, looks over nematode testing with nematologist Julius Passion at the company’s headquarter in Davis in 2016. The biotech firm on Wednesday reported a net loss of $31 million for all of 2016. Revenue increased to $14 million, up from $9.8 million in 2015. Manny Crisostomo Sacramento Bee file

Business & Real Estate

Marrone Bio sees revenue gains, but losses continue

March 29, 2017 1:58 PM

Comments

Videos